---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-041775"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2023-11-17T23:59:59+00:00"
generated_at: "2026-06-08T00:25:55.524741+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Semper Paratus furnishes investor presentation for proposed Tevogen Bio merger

## Summary
- Presentation provides additional detail on June 28, 2023 merger agreement between SPAC and Tevogen Bio.
- Transaction involves exchange of all Tevogen Bio capital stock for Semper Paratus Class A shares.
- Closing conditions include shareholder approval, regulatory clearances, and minimum cash requirements.
- No new financial projections or material updates disclosed in this filing beyond the presentation.

## SEC filing metadata
- accession: 0001493152-23-041775
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2023-11-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315223041775/0001493152-23-041775-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315223041775/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-041775
- JSON: https://secwatch.observer/filing/0001493152-23-041775.json
- Plain text: https://secwatch.observer/filing/0001493152-23-041775.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.